BioAtla (BCAB) Interest Expenses (2020 - 2026)

BioAtla's Interest Expenses history runs 7 years deep, the most recent figure standing at $20000.0 for Q1 2026.

• In Q1 2026, Interest Expenses fell 93.06% year-over-year to $20000.0; the TTM figure through Mar 2026 stood at $989000.0 (down 27.76% YoY), while the FY2025 annual figure was $115.9 million, up 12.93% from the prior year.
• Interest Expenses for Q1 2026 stood at $20000.0, down from $1.6 million in the prior quarter.
• The five-year high for Interest Expenses was $2.7 billion in Q3 2022, with the low at $5000.0 in Q4 2024.
• The 5-year median for Interest Expenses is $1.1 million (2023), against an average of $209.9 million.
• The sharpest annual moves came in 2022 and 2023: Interest Expenses soared 738735.95% in 2022, then tumbled 99.97% in 2023.
• BioAtla's Interest Expenses stood at $400000.0 in 2022, then plunged by 31.5% to $274000.0 in 2023, then slumped by 98.18% to $5000.0 in 2024, then surged by 32320.0% to $1.6 million in 2025, then sank by 98.77% to $20000.0 in 2026.
• Business Quant data shows BCAB's Interest Expenses at $20000.0 in Q1 2026, $1.6 million in Q3 2025, and $7.9 million in Q2 2025.